Literature DB >> 17933448

Antidepressant-like actions of minocycline combined with several glutamate antagonists.

Miguel Molina-Hernández1, Norma Patricia Tellez-Alcántara, Julian Pérez-García, Jorge Ivan Olivera-Lopez, M Teresa Jaramillo-Jaimes.   

Abstract

This study tested the potential antidepressant activity of minocycline alone or combined with two traditional antidepressant drugs or several glutamate receptor antagonists, using the time sampling method in the forced swimming test. Results showed that: desipramine (10.0 mg/kg, P<0.05; 15.0 mg/kg, P<0.05), minocycline (60.0 mg/kg, P<0.05; 80.0 mg/kg, P<0.05) and EMQMCM (1.5 mg/kg, P<0.05; 2.0 mg/kg, P<0.05), reduced immobility by increasing climbing. Fluoxetine (20.0 mg/kg, P<0.05; 25.0 mg/kg, P<0.05) reduced immobility by increasing swimming. MTEP (5.0 mg/kg, P<0.05; 10.0 mg/kg, P<0.05) and dizolcipine (1.0 mg/kg, P<0.05; 1.5 mg/kg, P<0.05) reduced immobility by increasing swimming and climbing. Combination experiments showed that a subthreshold dose of minocycline (50.0 mg/kg) synergized the antidepressant-like actions of subthreshold doses of: desipramine (5.0 mg/kg; P<0.05), EMQMCM (0.6 mg/kg; P<0.05), MTEP (2.5 mg/kg; P<0.05) and dizolcipine (0.5 mg/kg; P<0.05). In conclusion, minocycline produced antidepressant-like actions in the FST and subthreshold dose of minocycline combined with subthreshold dose of desipramine and several glutamate receptor antagonists and produced antidepressant-like actions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17933448     DOI: 10.1016/j.pnpbp.2007.09.004

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  44 in total

1.  Prior cold water swim stress alters immobility in the forced swim test and associated activation of serotonergic neurons in the rat dorsal raphe nucleus.

Authors:  R C Drugan; P T Hibl; K J Kelly; K F Dady; M W Hale; C A Lowry
Journal:  Neuroscience       Date:  2013-08-31       Impact factor: 3.590

Review 2.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 3.  Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.

Authors:  George Anderson; Michael Berk; Olivia Dean; Steven Moylan; Michael Maes
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 4.  The inflammation hypothesis in geriatric depression.

Authors:  George S Alexopoulos; Sarah Shizuko Morimoto
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-02       Impact factor: 3.485

Review 5.  The Central Nervous System and the Gut Microbiome.

Authors:  Gil Sharon; Timothy R Sampson; Daniel H Geschwind; Sarkis K Mazmanian
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

Review 6.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

7.  Microglia Loss Contributes to the Development of Major Depression Induced by Different Types of Chronic Stresses.

Authors:  Lijuan Tong; Yu Gong; Peng Wang; Wenfeng Hu; Jili Wang; Zhuo Chen; Wei Zhang; Chao Huang
Journal:  Neurochem Res       Date:  2017-04-22       Impact factor: 3.996

8.  Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors.

Authors:  Marta Imbesi; Tolga Uz; Radmila Manev; Rajiv P Sharma; Hari Manev
Journal:  Neurosci Lett       Date:  2008-10-07       Impact factor: 3.046

9.  Possible Role of Platelet GluR1 Receptors in Comorbid Depression and Cardiovascular Disease.

Authors:  Hu Chen
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-16

Review 10.  Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process.

Authors:  Helena M Abelaira; Gislaine Z Réus; Fabricia Petronilho; Tatiana Barichello; João Quevedo
Journal:  Neurochem Res       Date:  2014-07-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.